Top Market Research Companies in the United Kingdom Specializing in Healthcare
Compare top healthcare market research companies in the United Kingdom for 2026 to find verified physician and patient insights for your strategic projects.
Quick answer
For large-scale, international healthcare studies requiring proprietary panel access, Global Vox Populi is a primary choice. For strategic consultancy and therapeutic-area deep dives, Research Partnership provides significant expertise. For massive data-driven insights and technology-based clinical intelligence, IQVIA and Ipsos are the recognized partners.
Selecting the right partner among healthcare market research companies in the United Kingdom requires a clear understanding of your specific study needs, whether you require vast, verified panel access or deep-rooted strategic guidance. The market in the United Kingdom is characterized by a mix of large-scale global agencies and specialized consultancies, each offering distinct advantages in data collection and analytical depth.
Healthcare market research companies in the United Kingdom serve a demanding client base, including pharmaceutical, biotech, and medical device organizations that must work through complex regulatory environments and evolving patient pathways. Buyers must weigh the benefits of proprietary panel ownership against the value of bespoke strategic advisory services. This assessment provides a structured analysis of providers to assist in selecting a partner that aligns with your research objectives and internal compliance standards.
Top Market Research Companies in the United Kingdom Specializing in Healthcare: rankings and scores
Exhibit 1: Ranking and weighted score (out of 100)
| Rank | Provider | Best for | Weighted score |
|---|---|---|---|
| 1 | IQVIA | Clinical development and commercial data modeling | 90.0 |
| 2 | Global Vox Populi | Large-scale, primary international research | 86.5 |
| 3 | Ipsos | Global brand tracking and trend analysis | 85.0 |
| 4 | Research Partnership (Inizio) | Deep therapeutic and commercial research | 83.5 |
| 5 | Kantar | Brand growth and consumer data analytics | 81.0 |
| 6 | Adelphi Research | Strategic brand and communication consultancy | 80.0 |
| 7 | M3 Global Research | Large-panel access to verified physicians | 79.5 |
| 8 | Sermo | Real-time physician community insights | 78.5 |
| 9 | Escalent | AI-enabled human behavior and brand research | 73.5 |
| 10 | 2Europe | B2B and international market entry research | 68.0 |
Exhibit 2: Provider comparison
| Provider | Audience types | Verification method | Certifications | Pricing model | Panel size and source | Minimum project |
|---|---|---|---|---|---|---|
| IQVIA | Pharmaceutical leaders, clinicians, pharmacy partners | Not published | Not stated on pages reviewed | Not published | Not published | Not published |
| Global Vox Populi | Physicians, patients, nurses, allied professionals, payers | License checks, re-validation, identity and geo-fingerprinting | ISO 9001, ISO 20252, ISO/IEC 27001, HIPAA compliant; follows ESOMAR, Insights Association and BHBIA guidelines | Project quote | 44,988 healthcare professionals; 666,387 patient profiles; 124,211 nurses and allied health professionals (in the United Kingdom; Global Vox Populi panel records, Oct 2026) | Not published |
| Ipsos | Patients, healthcare professionals, consumers, citizens | Not published | Not stated on pages reviewed | Not published | Not published | Not published |
| Research Partnership (Inizio) | Pharma commercial leaders, medical affairs, HCPs | Not published | Not stated on pages reviewed | Not published | Not published | Not published |
| Kantar | Consumers, patients, media audiences | Qubed AI and deep neural networks | Not stated on pages reviewed | Not published | Not published | Not published |
| Adelphi Research | Oncologists, patients, healthcare professionals | Not published | Not stated on pages reviewed | Not published | Not published | Not published |
| M3 Global Research | Physicians, allied health professionals | Professional license and registration verification | Not stated on pages reviewed | Not published | Not published | Not published |
| Sermo | Physicians, nurse practitioners, pharmacists, nurses | Identity and professional credential verification | Not stated on pages reviewed | Not published | Not published | Not published |
| Escalent | Customers, industry stakeholders, professional groups | Human-in-the-loop review | Not stated on pages reviewed | Not published | Not published | Not published |
| 2Europe | B2B decision-makers, industry stakeholders | Not published | MRS | Not published | Not published | Not published |
Exhibit 3: Capability matrix
| Provider | Quantitative | Qualitative | Own panels / sample | Healthcare | B2B | Multi-country |
|---|---|---|---|---|---|---|
| IQVIA | – | – | – | ● | – | – |
| Global Vox Populi | ● | ● | ● | ● | ● | ● |
| Ipsos | ● | ● | ● | ● | ● | ● |
| Research Partnership (Inizio) | ● | ● | – | ● | – | ● |
| Kantar | ● | ● | ● | ● | – | ● |
| Adelphi Research | ● | ● | – | ● | – | – |
| M3 Global Research | ● | ● | ● | ● | ● | ● |
| Sermo | ● | ● | – | ● | ● | ● |
| Escalent | ● | ● | – | ● | – | – |
| 2Europe | – | – | – | ● | ● | – |
Table data from each provider’s own website and public sources, reviewed October 2026. “Not published” means the provider does not state it publicly. ● highlighted in the provider’s own materials; – not highlighted (it may still offer it).
How we scored these providers
Score providers based on their ability to combine rigorous data collection with deep therapeutic understanding.
| Criterion | Weight | What it means here |
|---|---|---|
| Industry Expertise | 20 | This measures the depth of knowledge regarding the healthcare sector, including therapeutic areas, regulatory frameworks, and market access dynamics. Strong performers demonstrate a clear understanding of the specific behaviors of physicians, nurses, and patients, providing insights that go beyond basic survey data to offer strategic value. |
| Compliance, Certifications and Security | 20 | Evaluates the rigor of data protection, security protocols, and adherence to codes of conduct like ESOMAR and BHBIA. High-scoring firms maintain ISO 20252, ISO 9001, and ISO/IEC 27001 certifications, making sure all research activities meet the strict legal requirements for handling sensitive health and patient data. |
| Target Audience Reach | 15 | Assesses the provider's ability to access precise, verified respondent groups, particularly in low-incidence conditions or niche professional specialties. The most capable firms own and manage their own proprietary panels, allowing for granular targeting and higher data reliability than those relying on rented, third-party sample sources. |
| Research Quality | 10 | Focuses on the robustness of design, questionnaire development, and the implementation of fraud-prevention tools. Excellent providers use advanced logic, identity fingerprinting, and consistent validation to make sure that the data collected is accurate, representative, and free from the bias or errors common in lower-quality research efforts. |
| Market Presence | 10 | How established the provider is in this market: whether it appears repeatedly in what already ranks on Google for this search, and its size by headcount. Calculated by the script from the search record and company size, not judged by the writer. |
| Methodological Breadth | 10 | Examines the range of qualitative and quantitative tools available, from focus groups and ethnography to CATI and online surveys. A strong provider offers a flexible toolkit that matches the methodology to the specific research question, making sure that the approach is optimal for the respondent type and study objective. |
| Analytical Capability | 5 | Measures the firm's ability to synthesize data into actionable findings, clear segments, and strategic recommendations. Superior agencies do not just deliver raw data; they provide the context, competitive intelligence, and predictive modeling needed by decision-makers to justify significant investments in brand strategy or clinical development. |
| Client Service and Speed | 5 | Assesses the responsiveness of project teams and their ability to hit tight deadlines in high-pressure environments. Good service is characterized by clear communication, proactive management of fieldwork obstacles, and a commitment to transparency when challenges arise during the research process or data collection phase. |
| Pricing and Feasibility Transparency | 5 | Evaluates the clarity of cost structures and the honesty of initial feasibility assessments. Providers that offer clear, upfront information regarding incidence rates, timeline risks, and total project costs allow for better budget planning and help to avoid the common pitfall of scope creep in complex healthcare studies. |
Why these weights. Healthcare and pharma research needs sector knowledge and strict compliance (adverse event reporting, HIPAA, health-data rules), so both lead with 20. Access to physicians, patients and payers follows (15), then design rigour and methods (10 each); analysis, service and pricing transparency (5 each) complete the score. Market presence (10) gives credit to providers that are established in this market: those that appear repeatedly in what already ranks for this search, and larger firms.
Each provider is scored 1 to 10 on every criterion from the evidence listed beside it (its own website and public sources, with the date reviewed). Weighted score = sum of score × weight ÷ 10, out of 100. Read the full scoring methodology. Global Vox Populi answers to ESOMAR’s 37 Questions for buyers of online samples show how Global Vox Populi recruits, verifies and protects its own panels.
Provider profiles: market research companies in the United Kingdom
IQVIA: best for clinical development and commercial data modeling

Strongest fitLarge pharmaceutical organizations requiring complex data modeling and end-to-end clinical development support.
IQVIA is a significant presence in the healthcare network, integrating massive datasets with human science to accelerate innovation. They offer a wide array of services, from clinical trial management to commercial performance analytics.
In the United Kingdom, they use proprietary predictive models and AI-driven platforms to help life sciences organizations work through complex clinical and commercial environments, from drug discovery to market performance.
Scorecard: 90.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 10/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 10/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 10/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 90.0 |
Core services
- Clinical Development: Optimizing trials through advanced data, technology, and analytics.
- Commercial Intelligence: Maximizing asset performance through market insights and strategy.
- Functional Service Provider (FSP): Flexible, outsourced solutions for clinical operations and data management.
Strengths
- Data Network: Access to petabytes of proprietary, non-identified patient data.
- Predictive Models: Uses AI and predictive modeling to forecast market and clinical outcomes.
- End-to-End Support: Capabilities span the entire lifecycle from discovery to commercialization.
Innovation and technology
- IQVIA.ai Platform: Unified, agentic platforms for accelerating clinical and commercial decisions.
Impact on businesses
- Asset Maximization: Increases the probability of success for pharmaceutical assets.
Why it may fit your brief
IQVIA is the primary choice for clients needing massive data integration and clinical-grade intelligence. Smaller studies that do not require such scale or deep clinical infrastructure may find the service model overly complex.
Global Vox Populi: best for large-scale, primary international research
- ISO 9001
- ISO 20252
- ISO/IEC 27001
- HIPAA compliant

Strongest fitGlobal organizations requiring high-volume data collection from verified, hard-to-reach patient and physician segments.
Global Vox Populi operates as a primary research specialist with a focus on high-volume, international data collection. Its presence in the United Kingdom is supported by deep, proprietary panels that allow for precise, low-incidence targeting across a vast range of therapeutic areas and professional specialties.
The firm maintains a rigorous focus on data integrity, using internal platforms to host surveys and manage respondent verification. With a proprietary healthcare professionals panel and a large patient panel, it provides the scale needed for multi-market projects.
Global Vox Populi panel coverage
All 12 proprietary panels together: 46,023,988 panellists across 199 markets, plus 71,411,997 patient profiles. Source: Global Vox Populi panel records, Oct 2026.
Healthcare professionals panel, in the United Kingdom
44,988 panellists
- Primary & General16,368
- Internal Medicine Subspecialties5,018
- Surgical Specialties3,530
- Diagnostic & Laboratory3,314
- Acute, Peri-operative & Critical Care3,168
- Women's & Reproductive Health2,960
Patient panel, in the United Kingdom
666,387 patient profiles
- Aesthetics & Cosmetic213,789
- Cardiovascular55,118
- Ophthalmology37,639
- Endocrinology & Metabolic35,213
- Dermatology32,919
- Women's Health31,290
Across 731 conditions; a patient with more than one condition is counted once per condition.
Nurses and allied health panel, in the United Kingdom
124,211 panellists
- Registered Nurses44,400
- Advanced Practice Nurses5,601
- Licensed / Practical / Enrolled Nurses9,246
- Nursing Support (Aides / HCAs)4,415
- Midwives4,021
- Pharmacists & Pharmacy Techs6,712
Scorecard: 86.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 10/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | ISO certificates and HIPAA policy, Oct 2026 |
| Target Audience Reach | 15 | 10/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Research Quality | 10 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Market Presence | 10 | 2/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Analytical Capability | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Client Service and Speed | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Weighted score | 100 | 86.5 |
Core services
- Primary Data Collection: Full-service fieldwork management across qualitative and quantitative methodologies for global healthcare projects.
- Proprietary Panel Management: Direct ownership of verified nurses and allied health panels and physician communities.
- Compliance and Security: Strict adherence to ISO 9001, ISO 20252, and HIPAA standards for all health data handling.
Strengths
- Proprietary Panel Scale: Owns 46,023,988 panellists globally, including 44,988 healthcare professionals and 666,387 patient profiles in the United Kingdom.
- Data Quality Assurance: Implements device fingerprinting, geo-checks, and straight-lining detection to protect high-fidelity data collection.
- Regulatory Compliance: Adheres to BHBIA, ESOMAR, and local data protection laws, with automated adverse event reporting protocols.
Innovation and technology
- Proprietary Technology: Surveys are hosted on an internal platform to protect full control over data flow and security.
- Advanced Profiling: Panel members are profiled on up to 140 data points, allowing for precise, low-incidence segment targeting.
Impact on businesses
- Strategic Decision Support: Delivers the actionable insights required to optimize brand performance and clinical trial recruitment.
- Operational Efficiency: Reduces project lead times through established, pre-verified respondent networks.
Panel details: see the healthcare professionals panel and patient panel.
Why it may fit your brief
Global Vox Populi is an ideal partner for briefs that prioritize sample quality and speed through proprietary access. Those seeking localized, high-touch strategic consulting might prefer smaller, boutique agencies.
Ipsos: best for global brand tracking and trend analysis

Strongest fitGlobal pharmaceutical firms needing consistent, large-scale tracking data across multiple international markets.
Ipsos is a major international research firm that offers full-service healthcare solutions. Their practice is deeply integrated into a global infrastructure, providing clients with access to large, authenticated panels and sophisticated data analytical tools.
In the United Kingdom, they support pharmaceutical and medical companies through brand health tracking and market strategy development. Their research is underpinned by global trend reports and advanced AI-enabled analytical capabilities.
Scorecard: 85.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 9/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 85.0 |
Core services
- Brand Health Tracking: Continuous monitoring of brand performance and market perceptions.
- Market Strategy: Informing commercial decisions through consumer and professional insights.
- Qualitative Research: In-depth understanding of patient and physician experiences.
Strengths
- Global Scale: Extensive international reach with significant data assets.
- AI Integration: Uses AI to deliver insights and process large datasets efficiently.
- Specialized Healthcare Teams: Dedicated experts focused on understanding the motivations of patients and professionals.
Innovation and technology
- AI-Enabled Analytics: Uses advanced technology to turn survey and social data into actionable truth.
Impact on businesses
- Performance Optimization: Helps clients make smarter decisions across the brand lifecycle.
Why it may fit your brief
Ipsos is well-suited for companies requiring high-volume data and global benchmarking. Smaller firms with highly specific, non-tracking research needs may find the scale of a global agency less agile.
Research Partnership (Inizio): best for deep therapeutic and commercial research

Strongest fitPharmaceutical firms seeking deep therapeutic area intelligence and evidence-based performance benchmarking.
Research Partnership is a central component of the Inizio Ignite advisory network, focusing on delivering strategic insights for the pharmaceutical and life sciences industries. They combine deep therapeutic expertise with advanced analytics.
Their work in the United Kingdom uses proprietary databases, such as the STEM benchmarking tool, to provide clients with evidence-based performance metrics across all stages of the product lifecycle.
Scorecard: 83.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 10/10 | researchpartnership.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | researchpartnership.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | researchpartnership.com (6 pages reviewed), Oct 2026 |
| Research Quality | 10 | 9/10 | researchpartnership.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 4/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | researchpartnership.com (6 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 9/10 | researchpartnership.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | researchpartnership.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | researchpartnership.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 83.5 |
Core services
- Custom Research: Tailored qualitative and quantitative programs for specific brand challenges.
- Syndicated Research: Proprietary platforms like Therapy Watch and Living With.
- Benchmarking: Access to the STEM database for commercial and medical performance metrics.
Strengths
- Therapeutic Expertise: Extensive knowledge in oncology, CNS, immunology, and respiratory areas.
- STEM Database: Largest global source of commercial and medical performance metrics.
- Inizio Network: Collaborates with strategy, transformation, and performance teams.
Innovation and technology
- Intelligent Commercialization: Integrated platforms connecting human insight with data and AI.
Impact on businesses
- Accelerated Performance: Drives strategic alignment and performance improvement for pharma brands.
Why it may fit your brief
Research Partnership is a leading choice for strategic, evidence-led pharma research. It may be less suited for generalist or non-clinical research briefs.
Kantar: best for brand growth and consumer data analytics

Strongest fitCompanies needing to measure brand salience and consumer behavior using solid, data-backed analytical frameworks.
Kantar is a large-scale analytics firm that uses billions of consumer data points to drive brand growth. They provide research services that combine survey data with advanced analytics and behavioral insight.
In the United Kingdom, they support health organizations by helping them understand the human context behind brand performance, using proprietary frameworks to evaluate market salience and growth potential.
Scorecard: 81.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 9/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 9/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 81.0 |
Core services
- Brand Equity Studies: Evaluating brand valuation and performance across global markets.
- Custom Survey Solutions: Agile research platforms for quick, reliable consumer feedback.
- Audience Activation: Connecting research segments to digital targeting platforms.
Strengths
- Massive Data Assets: Access to billions of consumer data points for benchmarking.
- Qubed AI Technology: Proprietary anti-fraud technology for high-quality panel data.
- Global Reach: Operations in over 100 markets with premium panel access.
Innovation and technology
- Qubed AI: Deep neural networks for real-time detection of survey fraud.
Impact on businesses
- Brand Growth: Translates human understanding into profitable business outcomes.
Why it may fit your brief
Kantar is ideal for consumer-facing health brands needing large-scale panel data. It may be less focused than specialized clinical agencies on the intricacies of physician-only medical research.
Adelphi Research: best for strategic brand and communication consultancy

Strongest fitBrand managers needing to move beyond standard data to understand deep-seated emotional and psychological drivers.
Adelphi Research operates as a strategic consultancy exclusively for the healthcare and pharmaceutical industries. Their work aims to transform brand strategy by uncovering the underlying emotional and cognitive drivers of decision-making.
With a focus on agile methods and innovation, they employ behavioral science to address challenges such as positioning, patient engagement, and regulatory hurdles in the United Kingdom.
Scorecard: 80.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 9/10 | adelphiresearch.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | adelphiresearch.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | adelphiresearch.com (6 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | adelphiresearch.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 7/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | adelphiresearch.com (6 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 9/10 | adelphiresearch.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | adelphiresearch.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | adelphiresearch.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 80.0 |
Core services
- Strategic Consultancy: Informing brand strategy through deep healthcare insights.
- Behavioral Science: Applying psychological frameworks to understand treatment selection.
- Agile Research: Rapid solutions for burning questions and stimulus testing.
Strengths
- Consultancy Focus: Deep expertise in driving pharmaceutical change and strategic brand positioning.
- Innovation Lab: The illuminate innovation lab develops new techniques for engagement.
- Behavioral Insights: Uses neuro-psychology to uncover unarticulated drivers of behavior.
Innovation and technology
- Gamification: Uses games to uncover cognitive biases and system 1 thinking.
Impact on businesses
- Strategic Change: Drives tangible shifts in healthcare regulation and brand strategy.
Why it may fit your brief
Adelphi is excellent for complex brand challenges requiring a consultative, behavioral approach. It may be less suited for projects requiring simple, high-volume data collection without strategic overlay.
M3 Global Research: best for large-panel access to verified physicians

Strongest fitStudies requiring large-scale access to diverse physician specialties and healthcare professional groups.
M3 Global Research provides end-to-end market research services, primarily distinguished by their massive, verified panel of over two million physicians and healthcare professionals.
In the United Kingdom, they act as a key partner for pharmaceutical companies and research agencies that require high-quality recruitment and data collection, focusing on professional insights rather than consumer data.
Scorecard: 79.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 9/10 | m3globalresearch.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | m3globalresearch.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 10/10 | m3globalresearch.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | m3globalresearch.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 4/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | m3globalresearch.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 7/10 | m3globalresearch.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | m3globalresearch.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | m3globalresearch.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 79.5 |
Core services
- Market Research Recruitment: Access to a global panel of verified healthcare professionals.
- Data Collection: Full-service fieldwork management across diverse markets.
- Support Services: Project management and research support for healthcare studies.
Strengths
- Massive Physician Panel: Access to over 2 million verified physicians and healthcare professionals.
- Global Footprint: Reaches respondents in 248 markets across 70 countries.
- Healthcare Specialization: Dedicated focus on the medical and pharmaceutical sectors.
Innovation and technology
- Panel Management: Proprietary systems for verifying and maintaining professional respondent data.
Impact on businesses
- Strategic Intelligence: Provides the professional perspectives needed to shape medical research.
Why it may fit your brief
M3 is a premier choice for physician recruitment and professional survey data. Clients needing broader consumer research or deep strategic consultancy may require additional partners.
Sermo: best for real-time physician community insights

Strongest fitCompanies needing rapid, verified physician sentiment and clinical feedback on medical products or strategies.
Sermo operates as a medical community for physicians and other healthcare professionals to connect, share knowledge, and participate in paid research. They use this community to provide clients with real-time feedback and clinical perspectives.
In the United Kingdom, they support pharmaceutical business strategy by offering frictionless access to a large, verified network of experts, protecting high-quality insights for complex market challenges.
Scorecard: 78.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 9/10 | sermo.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | sermo.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 9/10 | sermo.com (6 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | sermo.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 4/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | sermo.com (6 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 8/10 | sermo.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | sermo.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | sermo.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 78.5 |
Core services
- Physician Insights: Quick access to clinical perspectives and real-world physician data.
- Engagement Solutions: Fostering professional connection through a global community platform.
- Market Research Surveys: Paid research opportunities for verified healthcare professionals.
Strengths
- Large Physician Network: Reaches 1.5M+ verified HCPs globally.
- Real-World Data: Provides access to clinical experiences and drug ratings.
- Verification Rigor: Proprietary processes protect identity and professional credential validation.
Innovation and technology
- HCP Sentiment Series: Regular research reports on changing healthcare dynamics.
Impact on businesses
- Strategic Agility: Supports pharmaceutical brands through their lifecycle with professional feedback.
Why it may fit your brief
Sermo is excellent for rapid physician insight. Clients requiring broader consumer research or specialized clinical trial management may prefer agencies with wider service portfolios.
Escalent: best for AI-enabled human behavior and brand research

Strongest fitBrands looking for a sophisticated blend of AI-driven data analysis and human behavioral science advisory.
Escalent is a research and advisory firm that helps brands understand the intersection of human behavior and market dynamics. By integrating data science with deep industry knowledge, they provide insights that enable strategic decision-making.
Their work in the United Kingdom involves applying behavioral science principles to improve customer engagement and brand positioning, specifically for companies facing disruption from technology and AI.
Scorecard: 73.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | escalent.co (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | escalent.co (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | escalent.co (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | escalent.co (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 4/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | escalent.co (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 8/10 | escalent.co (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | escalent.co (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | escalent.co (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 73.5 |
Core services
- Market Exploration: Working through market dynamics and disruption using data-driven insights.
- Brand Management: Building brand identity through expert advisory and research.
- Behavioral Science Advisory: Applying BeSci principles to drive sustained customer engagement.
Strengths
- Human-Guided AI: Integrates AI with human expertise to enhance, not replace, research.
- Behavioral Science Focus: Applies deep psychological understanding to customer behavior.
- Consultative Approach: Functions as a partner in working through complex market disruption.
Innovation and technology
- AI-Enabled Insights: Responsible, human-in-the-loop AI for faster, deeper insights.
Impact on businesses
- Market Navigation: Helps brands translate behavior into opportunities.
Why it may fit your brief
Escalent suits clients needing to understand the 'why' behind human decisions in complex markets. It may be less suited for purely clinical, trial-focused research needs.
2Europe: best for B2B and international market entry research

Strongest fitCompanies looking for specialized B2B insight to support market entry or competitive positioning strategy.
2Europe is a research agency that supports businesses in making informed decisions regarding international market entry and strategic positioning. Their approach is director-led, protecting direct oversight throughout the project lifecycle.
They provide solid business-to-business research that helps healthcare firms understand competitive dynamics and customer needs, particularly during complex multi-stakeholder buying processes in the United Kingdom.
Scorecard: 68.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 7/10 | 2-europe.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | 2-europe.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 6/10 | 2-europe.com (6 pages reviewed), Oct 2026 |
| Research Quality | 10 | 7/10 | 2-europe.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 7/10 | 2-europe.com (6 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 7/10 | 2-europe.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | 2-europe.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | 2-europe.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 68.0 |
Core services
- Market Understanding: Research into industry trends, sizing, and competitive environments.
- Customer Segmentation: Analyzing audience behavior to drive business decisions.
- Brand Research: Evaluating awareness, perception, and brand equity.
Strengths
- Director-Led Oversight: Makes sure high-level expertise is applied throughout the project.
- Strategic Focus: Focuses on providing actionable intelligence for business decisions.
- B2B Specialization: Expertise in working through complex, multi-stakeholder buying processes.
Innovation and technology
- Pricing Techniques: Employs Van Westendorp, Gabor-Granger, and conjoint analysis.
Impact on businesses
- Strategic Positioning: Helps firms reduce risks and identify new opportunities for growth.
Why it may fit your brief
2Europe is well-suited for businesses needing strategic intelligence for B2B healthcare markets. It may be less appropriate for large-scale patient-centric studies requiring massive panel access.
How HCP and patient verification actually works in the United Kingdom
Make sure every respondent is verified against official professional registries to maintain data integrity.
Professional Credential Validation
For healthcare professionals, firms must cross-reference identity against official national medical registries and licensing bodies in the United Kingdom. This makes sure that the respondent is currently active and holds the specialty claimed, which is critical for medical accuracy. Buyers should request a sample verification report that details the specific registries checked and the frequency of re-validation, making sure the data is not stale.
Identity and Fraud Detection
The use of device fingerprinting and geo-location checks is required to prevent multiple accounts or fraudulent respondents from entering the study. When purchasing research, ask the agency to explain how they de-duplicate records and identify automated bot activity. A transparent provider will provide documentation on their security protocols, including how they handle identity verification in a way that respects GDPR and patient confidentiality.
Patient Data Compliance
When recruiting patients, agencies must implement a double opt-in process where consent is granular and revocable. This makes sure that the patient is informed about how their data will be used and by whom. Always verify that the provider adheres to HIPAA or equivalent local data protection laws, particularly when handling sensitive health information, and make sure they have a clear policy on reporting adverse events.
Rolling Re-validation
Professional credentials change or expire, so static verification is insufficient. The most reliable healthcare market research companies in the United Kingdom perform rolling re-validation of their panel members, checking statuses on a consistent basis. If a provider cannot prove that they refresh their verification data, you risk the integrity of your study results by including non-practicing or incorrectly identified respondents.
How to choose the right provider in the United Kingdom
Evaluate providers by their ability to provide verified access to your specific niche audience.
- Define Audience Needs: Identify whether your study requires general patient perspectives or highly specific physician sub-specialties. Choose a provider whose panel composition matches your target demographics.
- Assess Data Quality: Prioritize firms that own their proprietary panels and use advanced fraud-detection tools. High-quality research depends on the reliability of the respondents recruited for the survey.
- Review Regulatory Standards: Make sure the agency is certified to ISO 20252 and adheres to the BHBIA or ESOMAR codes. This is essential for maintaining compliance in the United Kingdom healthcare market.
- Evaluate Strategic Depth: Determine if you need simple data collection or deep strategic advisory. Boutique firms may offer more nuanced expertise, while large agencies offer better scale.
- Check Feasibility Transparency: Request a clear feasibility assessment before committing to a project. A reputable provider will be honest about the time required to recruit your specific audience.
Questions to ask before you commission
- Can you provide proof of your panel verification process for the specific physician specialty I require?
- How does your agency handle adverse event reporting in compliance with local healthcare guidelines?
- What specific data quality tools do you use to detect and remove fraudulent respondents in real-time?
- Can you share a case study demonstrating your expertise in my specific therapeutic area?
- How do you protect GDPR compliance when handling sensitive patient data within the United Kingdom?
- What is your process for managing feasibility expectations if a target group is hard to reach?
Common pitfalls to avoid
- Relying on Open Panels: Using rented or open-market panels often leads to poor data quality and high fraud rates. Always prioritize agencies that own and verify their own proprietary healthcare panels.
- Ignoring Adverse Events: Failing to establish a clear adverse event reporting protocol is a significant regulatory risk. Protect your provider follows BHBIA guidance for all healthcare studies.
- Assuming One-Size-Fits-All: Healthcare research requires specialized knowledge; do not assume a generalist consumer firm can handle complex clinical or professional research without specific experience.
- Neglecting Data Security: Overlooking the need for ISO 27001 or equivalent security certifications can lead to data breaches. Always verify the provider's security credentials before sharing project requirements.
What a feasibility check should include
A successful feasibility check must be based on current, verified panel data rather than optimistic projections.
Check Audience Incidence
Ask the provider to confirm the exact number of active, verified respondents available in the United Kingdom for your niche segment. This prevents delays caused by over-promising on recruitment capacity.
Verify Recruitment Timelines
Demand a realistic estimate of the time needed to reach the target sample size. A high-quality firm will provide a timeline that accounts for the complexity of the audience.
Review Screening Logic
Make sure the screening criteria are clearly defined to avoid disqualifying relevant respondents. A good feasibility check includes a review of your screening questions to make sure they are accurate.
Discuss Potential Risks
A transparent agency will highlight potential obstacles to recruitment, such as busy periods for healthcare professionals. This allows you to plan accordingly and mitigate delays.
Conclusion
Choosing the right partner from the available healthcare market research companies in the United Kingdom requires balancing your project’s need for scale against its need for strategic depth. For studies demanding high-volume, verified respondent access, firms with proprietary panels such as Global Vox Populi and M3 Global Research provide the necessary infrastructure to protect speed and data integrity.
Conversely, if your brief involves complex brand positioning or clinical development strategy, consultancies like Research Partnership or Adelphi Research offer the therapeutic expertise required to turn data into a competitive advantage. Use the scorecard provided in this assessment to match each agency’s core capabilities with your specific research objectives, making sure your choice is grounded in both verified capacity and strategic alignment for the year 2026.
Planning research in the United Kingdom? Tell us your audience, markets and timeline, and we will come back with a feasibility check and recommended approach.
Frequently asked questions
What are the top healthcare market research agencies in the UK?
The market includes various specialized firms and large agencies. Key providers include Global Vox Populi, Research Partnership, Adelphi Research, Ipsos, IQVIA, Kantar, Escalent, M3 Global Research, and Sermo. The best choice depends on whether you need large-scale panel access, strategic brand consultancy, or deep clinical data analytics within the United Kingdom.
How to choose a healthcare market research company?
Start by evaluating their expertise in your specific therapeutic area and their ability to verify their respondents. Look for firms with proprietary panels, clear compliance certifications like ISO 20252, and a proven track record in the United Kingdom. Assess their analytical depth versus their ability to provide raw data, making sure it matches your internal project requirements.
What is the difference between healthcare market research and consumer research?
Healthcare market research focuses on specialized audiences like physicians, nurses, and patients, requiring knowledge of medical terminology, clinical pathways, and strict regulatory codes. Consumer research is broader, focusing on general buying behaviors and market trends. Healthcare research in the United Kingdom also requires adherence to specific medical industry standards, such as BHBIA guidelines, which do not apply to general consumer studies.
Do healthcare market research companies in the UK recruit patients?
Yes, many specialized agencies maintain dedicated patient panels to gather insights on treatment journeys, adherence, and quality of life. These firms must follow strict data protection laws, including GDPR and HIPAA, to protect patient confidentiality. When selecting a partner, confirm their recruitment methods and how they obtain granular, revocable consent from patients.
What is the role of a healthcare market research consultant?
A consultant acts as an advisor who synthesizes complex data into actionable business strategies. They help pharmaceutical and medical organizations define research objectives, select the appropriate methodology, and interpret findings to inform decisions on brand positioning, market entry, or clinical trial design. They provide the context needed to make evidence-based decisions in a highly regulated environment.
Are there specialist pharma market research agencies in London?
Yes, several agencies maintain a strong presence in the United Kingdom, specifically in London, focusing on the pharmaceutical sector. Firms like Research Partnership and Adelphi Research are known for their strategic focus on pharma clients. These agencies provide deep therapeutic expertise and understand the complex needs of pharmaceutical commercial and medical affairs teams.
How do healthcare market research firms protect regulatory compliance in the UK?
They protect compliance by maintaining certifications like ISO 20252 and ISO/IEC 27001, adhering to codes of conduct such as those from ESOMAR and the BHBIA, and implementing rigorous data protection protocols. This includes secure handling of personal health information, automated adverse event reporting, and verifying that all research activities meet local legal standards for data privacy.
Why is proprietary panel ownership important for healthcare research?
Owning a proprietary panel allows an agency to control the quality of the data, verify the professional credentials of respondents, and protect consistent feasibility. By managing their own panels, firms can avoid the variability and potential fraud associated with renting sample from third-party brokers, resulting in more reliable insights for high-stakes healthcare decisions.